Consistent with previous reports (96, 98), BCL-2 protein expression was markedly increased in BCR-ABL transgenic mice, suggesting that BCL-2 plays a key role in the survival of CML cells. The gene discussed is BCL2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.